Learning Objectives:
- Understand mechanistic underpinnings in the development of cardiorenal syndrome.
- Review recent data from diuretic trials and juxtaposing them with data on rapid GDMT deployment.
- Understanding the concept of "renalism" as a barrier to optimizing decongestion and GDMT in patients with cardiorenal syndrome.
Session date:
05/31/2024 - 12:00pm to 1:00pm CDT
Location:
In-person / Zoom
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Janani Rangaswami, MD